References
Pharmacovigilance: the study of adverse drug reactions and related problems. Uppsala: WHO-UMC Annual Training Course, 2012 May 21–Jun 1
Cameron A, Roubos I, Ewen M, et al. Differences in the availability of medicines for chronic and acute conditions in the public and private sectors of developing countries. Bull World Health Organ 2011; 89(6): 412–21
Bakare N, Edwards IR, Stergachis A, et al. Global pharmacovigilance for antiretroviral drugs: overcoming contrasting priorities. PLoS Med. Epub 2011 Jul 5 [online]. Available from URL: http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.1001054 [Accessed 2012 Jun 21]
WHO-UMC. CemFlow (cohort event monitoring) [online]. Available from URL: http://who-umc.org/DynPage.aspx?id=98102&mn1=7347&mn2=7252&mn3=7254&mn4=7337 [Accessed 2012 Jun 21]
Acknowledgements
The author has no conflicts of interest that are directly relevant to the content of this editorial.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Edwards, I.R. Decision Dilemmas. Drug Saf 35, 611–614 (2012). https://doi.org/10.1007/BF03261957
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03261957